Table 1 Demographic and clinical characteristics of OBOT patient sample by HCV treatment status (N = 191)
Characteristics, n (%) | Total (N = 191) | No treatment (n = 133) | Any treatment (n = 58) | Early treatment, < 100 days (n = 18) | Late treatment, ≥ 100 days (n = 40) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Age at first OBOT program start | ||||||||||
20–34 | 37 | 19.4% | 26 | 19.5% | 11 | 19.0% | 3 | 16.7% | 8 | 20.0% |
35–44 | 54 | 28.3% | 39 | 29.3% | 15 | 25.9% | 5 | 27.8% | 10 | 25.0% |
45–64 | 82 | 42.9% | 55 | 41.4% | 27 | 46.6% | 9 | 50.0% | 18 | 45.0% |
65 + | 18 | 9.4% | 13 | 9.8% | 5 | 8.6% | 1 | 5.6% | 4 | 10.0% |
Female | 56 | 29.3% | 41 | 30.8% | 15 | 25.9% | 5 | 27.8% | 10 | 25.0% |
Race | ||||||||||
White/Caucasian | 147 | 77.0% | 103 | 77.4% | 44 | 75.9% | 14 | 77.8% | 30 | 75.0% |
Black/African American | 29 | 15.2% | 20 | 15.0% | 9 | 15.5% | 2 | 11.1% | 7 | 17.5% |
Other/multiracial1 | 15 | 7.9% | 10 | 7.5% | 5 | 8.6% | 2 | 11.1% | 3 | 7.5% |
Hispanic/LatinX ethnicity | 17 | 8.9% | 14 | 10.5% | 3 | 5.2% | 1 | 5.6% | 2 | 5.0% |
Primary insurance2 | ||||||||||
Medicaid | 120 | 62.8% | 79 | 59.4% | 41 | 71.9% | 13 | 72.2% | 28 | 70.0% |
Medicare | 32 | 16.8% | 24 | 18.1% | 8 | 14.0% | 1 | 5.6% | 7 | 17.5% |
Self-pay | 3 | 1.6% | 3 | 2.3% | 0 | 0% | 0 | 0% | 0 | 0% |
Other3 | 32 | 16.8% | 24 | 18.1% | 8 | 14.0% | 3 | 16.7% | 5 | 12.5% |
Time of HCV test positive4 | ||||||||||
Prior to or at OBOT start | 119 | 63.0% | 92 | 69.2% | 27 | 48.2% | 14 | 82.4% | 13 | 33.3% |
After OBOT start | 70 | 37.0% | 41 | 30.8% | 29 | 51.8% | 3 | 17.7% | 26 | 66.7% |
Medical co-morbidities | ||||||||||
HIV | 24 | 12.6% | 11 | 8.4% | 13 | 22.4% | 6 | 33.3% | 7 | 17.5% |
Diabetes | 29 | 15.2% | 20 | 15.0% | 9 | 15.5% | 3 | 16.7% | 6 | 15.0% |
Coronary artery disease | 24 | 12.6% | 14 | 10.5% | 10 | 17.2% | 3 | 16.7% | 7 | 17.5% |
Chronic kidney disease | 31 | 16.2% | 20 | 15.0% | 11 | 19.0% | 4 | 22.2% | 7 | 17.5% |
Cirrhosis | 25 | 13.1% | 14 | 10.5% | 11 | 19.0% | 4 | 22.2% | 7 | 17.5% |
Psychiatric co-morbidities | ||||||||||
Depression | 58 | 30.4% | 37 | 27.8% | 21 | 36.2% | 10 | 55.6% | 11 | 27.5% |
Anxiety/post-traumatic stress disorder | 108 | 56.5% | 78 | 58.6% | 30 | 51.7% | 9 | 50.0% | 21 | 52.5% |
Schizophrenia/psychotic disorder | 17 | 8.9% | 16 | 12.0% | 1 | 1.7% | 0 | 0.0% | 1 | 2.5% |
Bipolar disorder | 38 | 19.9% | 27 | 20.3% | 11 | 19.0% | 4 | 22.2% | 7 | 17.5% |
Median duration in OBOT in days (IQR) | 146 | (58–382) | 90 | (46–216) | 398 | (157–854) | 284 | (157–796) | 430 | (148–860) |